News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bard Endoscopic Technologies (BCR) Closes Transaction to Acquire SenoRx, Inc. (SENO)



7/6/2010 1:43:29 PM

MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today announced that it has closed the previously disclosed acquisition of the outstanding shares of SenoRx, Inc. With the transaction completed, the SenoRx organization is now part of Bard’s Peripheral Vascular division.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES